- NEWS
- Correction 16 August 2022
Long-lasting HIV prevention drug could be game changer — but who will pay?
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 608, 460-461 (2022)
doi: https://doi.org/10.1038/d41586-022-02123-x
Updates & Corrections
-
Correction 16 August 2022: An earlier version of this article incorrectly stated the full name of Wits Reproductive Health and HIV Institute (Wits RHI).
References
Delany-Moretlwe, S. et al. Lancet 339, 1779–1789 (2022).
Jamieson, L. et al. Preprint at SSRN https://doi.org/10.2139/ssrn.4047136 (2022).